A/61/338 Contents Page I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1–6 4 II. Reducing maternal mortality: the contribution of the right to health . . . . . . . . . . . 7–36 5 A. Right-to-health norms and obligations relevant to maternal mortality . . . . . . 13–21 6 B. What can the right to health add to policies and programmes to reduce maternal mortality? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22–30 8 The need for a human rights campaign against maternal mortality . . . . . . . . 31–36 10 The human right to medicines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37–93 10 A. The responsibilities of States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47–81 13 B. The responsibilities of pharmaceutical companies . . . . . . . . . . . . . . . . . . . . . . 82–93 19 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94–96 21 C. III. IV. 06-51997 Paragraphs 3